NEW PRIMARY NONMELANOMA SKIN-CANCER IN PATIENTS WITH A HISTORY OF SQUAMOUS-CELL CARCINOMA OF THE SKIN

被引:54
|
作者
FRANKEL, DH
HANUSA, BH
ZITELLI, JA
机构
[1] UNIV SO CALIF,SCH MED,DERMATOL SECT,LOS ANGELES,CA 90033
[2] UNIV PITTSBURGH,DEPT MED,PITTSBURGH,PA 15260
[3] UNIV PITTSBURGH,MONTEFIORE HOSP,CTR HLTH,DEPT MED & SURG,PITTSBURGH,PA 15213
关键词
D O I
10.1016/0190-9622(92)70100-T
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background. Rational follow-up guidelines for skin cancer patients should be based on the risk of three separate events: cancer recurrence, cancer metastasis, and the development of subsequent skin cancers. However, currently no guidelines exist for follow-up of patients with squamous cell carcinoma of the skin (SCC), which take into account all three of these risks. Objective. The purpose of this study is to establish rational minimum guidelines for follow-up of patients with SCC. To do this, we first must determine the risk of SCC patients for the development of subsequent skin cancers. Combining these data with previously published data on SCC recurrence and SCC metastasis, we then propose guidelines for follow-up of patients with SCC. Methods. We followed up 101 SCC patients on a yearly basis for 5 years after treatment and recorded the date and site of subsequent nonmelanoma skin cancers (NMSCs). Results. Thirty percent of SCC patients developed additional SCCs and 52% developed subsequent NMSCs within 5 years of therapy for their first SCC. Patients showing the highest risk of subsequent NMSC were those presenting with multiple SCC, SCC greater than 1 cm in diameter, SCC requiring more than 1 Mohs surgery layer to remove, or SCC occurring on the scalp, ear, nose, or extremities. One hundred percent of subsequent NMSCs were detected by the fourth year of follow-up; 54% of these occurred within the first year of follow-up. Conclusion: After combining our data with previously published studies of SCC recurrence and metastasis, we recommend that all patients with SCC be followed up for at least 4 years after treatment. Moreover, because most subsequent NMSCs, SCC recurrences, and SCC metastases developed early in the follow-up period, we recommend that patients be reexamined at least every 3 months during the first year of follow-up and every 6 months thereafter. It must be stressed that these are meant as minimum follow-up guidelines.
引用
收藏
页码:720 / 726
页数:7
相关论文
共 50 条
  • [41] Nonmelanoma skin cancer - from actinic keratosis to cutaneous squamous cell carcinoma
    Schmitz, Lutz
    Oster-Schmidt, Claus
    Stockfleth, Eggert
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 (08): : 1002 - 1013
  • [42] IMMUNOSUPPRESSION IN PATIENTS WITH METASTATIC SQUAMOUS-CELL CARCINOMA FROM THE SKIN
    DINEHART, SM
    CHU, DZJ
    MANERS, AW
    POLLACK, SV
    JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1990, 16 (03): : 271 - 274
  • [43] A ROLE FOR SUNLIGHT IN SKIN-CANCER - UV-INDUCED P53 MUTATIONS IN SQUAMOUS-CELL CARCINOMA
    BRASH, DE
    RUDOLPH, JA
    SIMON, JA
    LIN, A
    MCKENNA, GJ
    BADEN, HP
    HALPERIN, AJ
    PONTEN, J
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (22) : 10124 - 10128
  • [44] GRENZ RAY INDUCED NONMELANOMA SKIN-CANCER
    FRENTZ, G
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1989, 21 (03) : 475 - 478
  • [45] MERKEL CELL-CARCINOMA, A NEW TYPE OF SKIN-CANCER
    ARRAZTOA, J
    ODDO, D
    FERRADA, C
    RISTORI, L
    SOLA, A
    ARRAZTOA, JA
    REVISTA MEDICA DE CHILE, 1987, 115 (04) : 337 - 343
  • [46] C-FOS EXPRESSION IN NORMAL SKIN AND NONMELANOMA SKIN-CANCER
    TAKAHASHI, S
    PEARSE, AD
    MARKS, R
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1991, 96 (06) : 1026 - 1026
  • [47] SQUAMOUS-CELL CARCINOMA OF THE VULVA METASTASIZING TO THE SKIN
    KULKARNI, R
    BRADFORD, WP
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1995, 74 (07) : 571 - 572
  • [48] ADENOID (ACANTHOLYTIC) SQUAMOUS-CELL CARCINOMA OF THE SKIN
    NAPPI, O
    PETTINATO, G
    WICK, MR
    JOURNAL OF CUTANEOUS PATHOLOGY, 1989, 16 (03) : 114 - 121
  • [49] COLLAGENOLYTIC ACTIVITIES OF SQUAMOUS-CELL CARCINOMA OF SKIN
    HASHIMOTO, K
    YAMANISHI, Y
    MAEYENS, E
    DABBOUS, MK
    KANZAKI, T
    CANCER RESEARCH, 1973, 33 (11) : 2790 - 2801
  • [50] SQUAMOUS-CELL CARCINOMA OF SKIN WITH PERINEURAL INVASION
    LAWRENCE, N
    COTTEL, WI
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1994, 31 (01) : 30 - 33